The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla
Open accessAbstract
Previous authors have shown that the transverse relaxivity R(2)* and frequency shifts that characterize gradient echo signal decay in magnetic resonance imaging are closely associated with the distribution of iron and myelin in the brain's white matter. In multiple sclerosis, iron accumulation in brain tissue may reflect a multiplicity of pathological processes. Hence, iron may have the unique potential to serve as an in vivo magnetic resonance imaging tracer of disease pathology. To investigate the ability of iron in tracking multiple sclerosis-induced pathology by magnetic resonance imaging, we performed qualitative histopathological analysis of white matter lesions and normal-appearing white matter regions with variable appearance on gradient echo magnetic resonance imaging at 7 Tesla. The samples used for this study derive from two patients with multiple sclerosis and one non-multiple sclerosis donor. Magnetic resonance images were acquired using a whole body 7 Tesla magnetic resonance imaging scanner equipped with a 24-channel receive-only array designed for tissue imaging. A 3D multi-gradient echo sequence was obtained and quantitative R(2)* and phase maps were reconstructed. Immunohistochemical stainings for myelin and oligodendrocytes, microglia and macrophages, ferritin and ferritin light polypeptide were performed on 3- to 5-µm thick paraffin sections. Iron was detected with Perl's staining and 3,3'-diaminobenzidine-tetrahydrochloride enhanced Turnbull blue staining. In multiple sclerosis tissue, iron presence invariably matched with an increase in R(2)*. Conversely, R(2)* increase was not always associated with the presence of iron on histochemical staining. We interpret this finding as the effect of embedding, sectioning and staining procedures. These processes likely affected the histopathological analysis results but not the magnetic resonance imaging that was obtained before tissue manipulations. Several cellular sources of iron were identified. These sources included oligodendrocytes in normal-appearing white matter and activated macrophages/microglia at the edges of white matter lesions. Additionally, in white matter lesions, iron precipitation in aggregates typical of microbleeds was shown by the Perl's staining. Our combined imaging and pathological study shows that multi-gradient echo magnetic resonance imaging is a sensitive technique for the identification of iron in the brain tissue of patients with multiple sclerosis. However, magnetic resonance imaging-identified iron does not necessarily reflect pathology and may also be seen in apparently normal tissue. Iron identification by multi-gradient echo magnetic resonance imaging in diseased tissues can shed light on the pathological processes when coupled with topographical information and patient disease history.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, degeneration of cells in the brain also result in the deposition of iron in the extracellular space, which then induces waves of oxidative stress (via Fenton chemistry) in these brain regions (Craelius et al., 1982; Bagnato et al., 2011).”
From The Role of Iron Regulation in Immunometabolism and Immune-Related Disease (2019) · cites this paper as Bagnato et al., 2011
In the citing paper
“In-vivo and post-mortem investigations suggest focal iron accumulation in the white matter in multiple sclerosis160,161,206 and focal iron accumulation in the cortex in amyotrophic lateral sclerosis207 co-localise with microglia (appendix).160,207”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [160]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
American Journal of Neuroradiology
(2020) · American Journal of Neuroradiology · doi:10.3174/ajnr · Cited by 2,468
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
Smith, M. A., Harris, P. L. R., Sayre, L. M., & Perry, G. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9866 · Cited by 1,365
The Immunopathology of Multiple Sclerosis: An Overview
Lassmann, H., Brück, W., & Lucchinetti, C. F. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00064.x · Cited by 1,182
High-field MRI of brain cortical substructure based on signal phase
Duyn, J. H., van Gelderen, P., Li, T., de Zwart, J. A., Koretsky, A. P., & Fukunaga, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610821104 · Cited by 641
Oligodendrocytes and myelination: The role of iron
Todorich, B., Pasquini, J. M., Garcia, C. I., Paez, P. M., & Connor, J. R. (2008) · Glia · doi:10.1002/glia.20784 · Cited by 615
Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data
Shmueli, K., de Zwart, J. A., van Gelderen, P., Li, T., Dodd, S. J., & Duyn, J. H. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22135 · Cited by 529
Immunopathology of secondary‐progressive multiple sclerosis
Prineas, J. W., Kwon, E. E., Cho, E., Sharer, L. R., Barnett, M. H., Oleszak, E. L., Hoffman, B. E., & Morgan, B. P. (2001) · Annals of Neurology · doi:10.1002/ana.1255 · Cited by 453
Diagnostic Criteria for Neuropathologic Assessment of Alzheimer’s Disease
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00062-6 · Cited by 410
Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast
Fukunaga, M., Li, T.-Q., van Gelderen, P., de Zwart, J. A., Shmueli, K., Yao, B., Lee, J., Maric, D., Aronova, M. A., Zhang, G., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911177107 · Cited by 408
Gelman, N., Gorell, J. M., Barker, P. B., Savage, R. M., Spickler, E. M., Windham, J. P., & Knight, R. A. (1999) · Radiology · doi:10.1148/radiology.210.3.r99fe41759 · Cited by 373
Research works printed but not linked: 7
- Craelius, 1982, Archives of pathology & laboratory medicine, 106, 397
- Curnes, 1988, American Journal of Neuroradiology, 9, 1061
- 1964, Acta neurologica Scandinavica. Supplementum, 40, 9
- 2011, Neuroscience letters, 400, 36
- 2005, COOLEYS ANEMIA EIGHT SYMP, 1054, 379
- 1984, Archives of pathology, 108, 755
- 2010, PROC INTL SOC MAG RESON MED, 18, 5124
Cited by
Sorted by citations
The role of iron in brain ageing and neurodegenerative disorders
Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819
Pathological mechanisms in progressive multiple sclerosis
Mahad, D., Trapp, B. D., & Lassmann, H. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70256-x · Cited by 1,198
Progressive multiple sclerosis: pathology and pathogenesis
Lassmann, H., van Horssen, J., & Mahad, D. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.168 · Cited by 1,033
Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker
Wang, Y., & Liu, T. (2015) · Magnetic Resonance in Medicine · doi:10.1002/mrm.25358 · Cited by 878
A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosis
Absinta, M., Maric, D., Gharagozloo, M., Garton, T., Smith, M. D., Jin, J., Fitzgerald, K. C., Song, A., Liu, P., Lin, J.-P., et al. (2021) · Nature · doi:10.1038/s41586-021-03892-7 · Cited by 768
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis
Friese, M. A., Schattling, B., & Fugger, L. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.37 · Cited by 628
Iron and neurodegeneration in the multiple sclerosis brain
Hametner, S., Wimmer, I., Haider, L., Pfeifenbring, S., Brück, W., & Lassmann, H. (2013) · Annals of Neurology · doi:10.1002/ana.23974 · Cited by 519
Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo
Absinta, M., Sati, P., Masuzzo, F., Nair, G., Sethi, V., Kolb, H., Ohayon, J., Wu, T., Cortese, I. C. M., & Reich, D. S. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.2399 · Cited by 534
The role of zinc, copper, manganese and iron in neurodegenerative diseases
Mezzaroba, L., Alfieri, D. F., Colado Simão, A. N., & Vissoci Reiche, E. M. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.07.007 · Cited by 524
Association between pathological and MRI findings in multiple sclerosis
Filippi, M., Rocca, M. A., Barkhof, F., Brück, W., Chen, J. T., Comı, G., DeLuca, G. C., Stefano, N. D., Erickson, B. J., Evangelou, N., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70003-0 · Cited by 499
Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging
Dal-Bianco, A., Grabner, G., Kronnerwetter, C., Weber, M., Höftberger, R., Berger, T., Auff, E., Leutmezer, F., Trattnig, S., Lassmann, H., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1636-z · Cited by 463
Self-citationon behalf of the MAGNIMS study group, Rovira, À., Wattjes, M. P., Tintoré, M., Tur, C., Yousry, T. A., Sormani, M. P., De Stefano, N., Filippi, M., Auger, C., et al. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.106 · Cited by 423
Haider, L., Simeonidou, C., Steinberger, G., Hametner, S., Grigoriadis, N., Deretzi, G., Kovács, G. G., Kutzelnigg, A., Lassmann, H., & Frischer, J. M. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-307712 · Cited by 365
Overview of quantitative susceptibility mapping
Deistung, A., Schweser, F., & Reichenbach, J. R. (2017) · NMR in Biomedicine · doi:10.1002/nbm.3569 · Cited by 338
Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions
Absinta, M., Sati, P., Schindler, M., Leibovitch, E. C., Ohayon, J., Wu, T., Meani, A., Filippi, M., Jacobson, S., Cortese, I. C. M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86198 · Cited by 327
The Role of Iron Regulation in Immunometabolism and Immune-Related Disease
Cronin, S. J. F., Woolf, C. J., Weiss, G., & Penninger, J. M. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00116 · Cited by 299
Epidemiology and treatment of multiple sclerosis in elderly populations
Vaughn, C. B., Jakimovski, D., Kavak, K. S., Ramanathan, M. K., Benedict, R. H. B., Zivadinov, R., & Weinstock‐Guttman, B. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0183-3 · Cited by 320
Pathology of multiple sclerosis and related inflammatory demyelinating diseases
Kutzelnigg, A., & Lassmann, H. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52001-2.00002-9 · Cited by 315
Wang, Y., Spincemaille, P., Liu, Z., Dimov, A., Deh, K., Li, J., Zhang, Y., Yao, Y., Gillen, K. M., Wilman, A. H., et al. (2017) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25693 · Cited by 285
Visualization of nigrosome 1 and its loss in PD
Blazejewska, A. I., Schwarz, S. T., Pitiot, A., Stephenson, M. C., Lowe, J. S., Bajaj, N. P. S., Bowtell, R. W., Auer, D. P., & Gowland, P. A. (2013) · Neurology · doi:10.1212/wnl.0b013e31829e6fd2 · Cited by 269
Pathology and disease mechanisms in different stages of multiple sclerosis
Lassmann, H. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.05.010 · Cited by 224
Iron in multiple sclerosis: roles in neurodegeneration and repair
Stephenson, E. L., Nathoo, N., Mahjoub, Y., Dunn, J. F., & Yong, V. W. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.118 · Cited by 253
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging
Ciccarelli, O., Barkhof, F., Bodini, B., Stefano, N. D., Golay, X., Nicolay, K., Pelletier, D., Pouwels, P. J. W., Smith, S. A., Wheeler‐Kingshott, C. A. M. G., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70101-2 · Cited by 253
Quantitative Susceptibility Mapping of Multiple Sclerosis Lesions at Various Ages
Chen, W., Gauthier, S. A., Gupta, A. K., Comunale, J. P., Liu, T., Wang, S., Pei, M., Pitt, D., & Wang, Y. (2013) · Radiology · doi:10.1148/radiol.13130353 · Cited by 236
Wisnieff, C., Ramanan, S., Olesik, J., Gauthier, S., Wang, Y., & Pitt, D. (2015) · Magnetic Resonance in Medicine · doi:10.1002/mrm.25420 · Cited by 245
Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI
Dal‐Bianco, A., Grabner, G., Kronnerwetter, C., Weber, M., Kornek, B., Kasprian, G. J., Berger, T., Leutmezer, F., Rommer, P. S., Trattnig, S., et al. (2020) · Brain · doi:10.1093/brain/awaa436 · Cited by 230
Iron, myelin, and the brain: neuroimaging meets neurobiology
Möller, H. E., Bossoni, L., Connor, J. R., Crichton, R. R., Does, M. D., Ward, R. J., Zecca, L., Zucca, F. A., & Ronen, I. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.03.009 · Cited by 207
Contributions to magnetic susceptibility of brain tissue
Duyn, J. H., & Schenck, J. F. (2016) · NMR in Biomedicine · doi:10.1002/nbm.3546 · Cited by 223
Iron Is a Sensitive Biomarker for Inflammation in Multiple Sclerosis Lesions
Mehta, V. B., Pei, W., Yang, G., Li, S., Swamy, E., Boster, A. L., Schmalbrock, P., & Pitt, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057573 · Cited by 209
Imaging chronic active lesions in multiple sclerosis: a consensus statement
Bagnato, F. R., Sati, P., Hemond, C. C., Elliott, C., Gauthier, S. A., Harrison, D. M., Mainero, C., Oh, J., Pitt, D., Shinohara, R. T., et al. (2024) · Brain · doi:10.1093/brain/awae013 · Cited by 207
Kaunzner, U. W., Kang, Y., Zhang, S., Morris, E., Yao, Y., Pandya, S., Hurtado Rua, S. M., Park, C., Gillen, K. M., Nguyen, T. D., et al. (2019) · Brain · doi:10.1093/brain/awy296 · Cited by 199
Mechanisms of white matter damage in multiple sclerosis
Lassmann, H. (2014) · Glia · doi:10.1002/glia.22597 · Cited by 191
Self-citationKey clinical benefits of neuroimaging at 7 T
Trattnig, S., Springer, E., Bogner, W., Hangel, G. J., Strasser, B., Dymerska, B., Cardoso, P. L., & Robinson, S. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.11.031 · Cited by 183
Microglia in multiple sclerosis: protectors turn destroyers
Yong, V. W. (2022) · Neuron · doi:10.1016/j.neuron.2022.06.023 · Cited by 185
χ-separation: Magnetic susceptibility source separation toward iron and myelin mapping in the brain
Shin, H., Lee, J., Yun, Y. H., Yoo, S. H., Jang, J., Oh, S., Nam, Y., Jung, S., Kim, S., Fukunaga, M., et al. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118371 · Cited by 201
Absinta, M., Sati, P., Gaitán, M. I., Maggi, P., Cortese, I. C. M., Filippi, M., & Reich, D. S. (2013) · Annals of Neurology · doi:10.1002/ana.23959 · Cited by 165
A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging
Mainero, C., Louapre, C., Govindarajan, S. T., Giannì, C., Nielsen, A. S., Cohen‐Adad, J., Sloane, J. A., & Kinkel, R. P. (2015) · Brain · doi:10.1093/brain/awv011 · Cited by 167
Advances in the immunopathogenesis of multiple sclerosis
Yadav, S. K., Mindur, J. E., Ito, K., & Dhib-Jalbut, S. S. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000205 · Cited by 173
Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis
Yong, H. Y. F., & Yong, V. W. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00581-x · Cited by 170
Cerebral Iron Deposition in Neurodegeneration
Dušek, P., Hofer, T., Alexander, J., Roos, P. M., & Aaseth, J. (2022) · Biomolecules · doi:10.3390/biom12050714 · Cited by 170
Advanced MRI and staging of multiple sclerosis lesions
Absinta, M., Sati, P., & Reich, D. S. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.59 · Cited by 161
Adamczyk, B., & Adamczyk-Sowa, M. H. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1973834 · Cited by 155
Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA)
Schneider, S. A., Dušek, P., Hardy, J., Westenberger, A., Jankovic, J. J., & Bhatia, K. P. (2013) · Current Neuropharmacology · doi:10.2174/157015913804999469 · Cited by 140
MRI in the assessment and monitoring of multiple sclerosis: an update on best practice
Kaunzner, U. W., & Gauthier, S. A. (2017) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285617708911 · Cited by 143
Multiple Sclerosis: Molecular Mechanisms and Therapeutic Opportunities
Miljković, D. M., & Spasojević, I. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.5068 · Cited by 143
Identification of Chronic Active Multiple Sclerosis Lesions on 3T MRI
Absinta, M., Sati, P., Fechner, A., Schindler, M. K., Nair, G., & Reich, D. S. (2018) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5660 · Cited by 140
Inflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple Sclerosis
Haider, L. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/725370 · Cited by 141
Value of 3T Susceptibility-Weighted Imaging in the Diagnosis of Multiple Sclerosis
Clarke, M. A., Pareto, D., Pessini, L. M., Arrambide, G., Alberich, M., Crescenzo, F., Cappelle, S., Tintoré, M., Sastre‐Garriga, J., Auger, C., et al. (2020) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6547 · Cited by 135
Superficial white matter imaging: Contrast mechanisms and whole-brain in vivo mapping
Kirilina, E. P., Helbling, S., Morawski, M., Pine, K., Reimann, K., Jankuhn, S., Dinse, J., Deistung, A., Reichenbach, J. R., Trampel, R., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaz9281 · Cited by 121
Dulamea, A. O. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-47861-6_7 · Cited by 128
Redox metals homeostasis in multiple sclerosis and amyotrophic lateral sclerosis: a review
Sheykhansari, S., Kozielski, K., Bill, J., Sitti, M., Gemmati, D., Zamboni, P., & Singh, A. V. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0379-2 · Cited by 124
Comparison of Routine Brain Imaging at 3 T and 7 T
Springer, E., Dymerska, B., Cardoso, P. L., Robinson, S., Weisstanner, C., Wiest, R., Schmitt, B., & Trattnig, S. (2016) · Investigative Radiology · doi:10.1097/rli.0000000000000256 · Cited by 114
Roles and regulation of microglia activity in multiple sclerosis: insights from animal models
Distéfano‐Gagné, F., Bitarafan, S., Lacroix, S., & Gosselin, D. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-023-00709-6 · Cited by 115
Iron in Multiple Sclerosis and Its Noninvasive Imaging with Quantitative Susceptibility Mapping
Stüber, C., Pitt, D., & Wang, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010100 · Cited by 117
Effects of formalin fixation and temperature on MR relaxation times in the human brain
Birkl, C., Langkammer, C., Golob‐Schwarzl, N., Leoni, M., Haybaeck, J., Goessler, W., Fazekas, F., & Ropele, S. (2016) · NMR in Biomedicine · doi:10.1002/nbm.3477 · Cited by 111
Brain iron accumulation in aging and neurodegenerative disorders
Hagemeier, J., Geurts, J. J. G., & Zivadinov, R. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.128 · Cited by 114
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis
Calabrese, M., Preziosa, P., Scalfari, A., Colato, E., Marastoni, D., Absinta, M., Battaglini, M., Stefano, N. D., Filippo, M. D., Hametner, S., et al. (2024) · Annals of Neurology · doi:10.1002/ana.26913 · Cited by 115
Stankiewicz, J., Neema, M., & Ceccarelli, A. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.039 · Cited by 110
Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis
Maggi, P., Kühle, J., Schädelin, S., van der Meer, F., Weigel, M., Galbusera, R., Mathias, A., Lu, P., Rahmanzadeh, R., Benkert, P., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012326 · Cited by 112
Albumin and multiple sclerosis
LeVine, S. M. (2016) · BMC Neurology · doi:10.1186/s12883-016-0564-9 · Cited by 105
Scalfari, A., Traboulsee, A. L., Oh, J., Airas, L. M., Bittner, S., Calabrese, M., García‐Domínguez, J. M., Granziera, C., Greenberg, B. M., Hellwig, K., et al. (2024) · Annals of Neurology · doi:10.1002/ana.27034 · Cited by 107
Zhang, Y., Gauthier, S. A., Gupta, A. K., Comunale, J. P., Chiang, G. C.-Y., Zhou, D., Chen, W., Giambrone, A. E., Zhu, W., & Wang, Y. (2016) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25144 · Cited by 92
Multiple Sclerosis: Validation of MR Imaging for Quantification and Detection of Iron
Walsh, A. J. L., Lebel, R. M., Eissa, A., Blevins, G., Catz, I., Lu, J., Resch, L., Johnson, E. S., Emery, D. J., Warren, K. G., et al. (2013) · Radiology · doi:10.1148/radiol.12120863 · Cited by 92
Li, X., Chen, L., Kutten, K. S., Ceritoglu, C., Li, Y., Kang, N., Hsu, J. T., Qiao, Y., Wei, H., Liu, C., et al. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.02.016 · Cited by 96
Relationship between paramagnetic rim lesions and slowly expanding lesions in multiple sclerosis
Calvi, A., Clarke, M. A., Prados, F., Chard, D., Ciccarelli, O., Alberich, M., Pareto, D., Rodríguez, M., Sastre‐Garriga, J., Tur, C., et al. (2022) · Multiple Sclerosis Journal · doi:10.1177/13524585221141964 · Cited by 97
Lesion Heterogeneity on High-Field Susceptibility MRI Is Associated with Multiple Sclerosis Severity
Harrison, D. M., Li, X., Liu, H., Jones, C. K., Caffo, B. S., Calabresi, P. A., & van Zijl, P. C. M. (2016) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4726 · Cited by 89
Gillen, K. M., Mubarak, M., Nguyen, T. D., & Pitt, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00255 · Cited by 88
Magnetic susceptibility contrast variations in multiple sclerosis lesions
Li, X., Harrison, D. M., Liu, H., Jones, C. K., Oh, J., Calabresi, P. A., & van Zijl, P. C. M. (2015) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24976 · Cited by 88
Schweser, F., Martins, A. L. R. D., Hagemeier, J., Lin, F., Hanspach, J., Weinstock‐Guttman, B., Hametner, S., Bergsland, N., Dwyer, M. G., & Zivadinov, R. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.10.063 · Cited by 91
A New Advanced MRI Biomarker for Remyelinated Lesions in Multiple Sclerosis
Rahmanzadeh, R., Galbusera, R., Lu, P., Bahn, E., Weigel, M., Baraković, M., Franz, J., Nguyen, T. D., Spincemaille, P., Schiavi, S., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26441 · Cited by 87
Zarruk, J. G., Berard, J. L., dos Santos, R. P., Kroner, A., Lee, J., Arosio, P., & David, S. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.02.001 · Cited by 79
Chawla, S., Kister, I., Wuerfel, J. T., Brisset, J., Liu, S., Sinnecker, T., Dušek, P., Haacke, E. M., Paul, F., & Ge, Y. (2016) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4729 · Cited by 82
Bian, W., Harter, K., Hammond, K. E., Lupo, J., Xu, D., Kelley, D. A. C., Vigneron, D. B., Nelson, S. J., & Pelletier, D. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512447870 · Cited by 81
QSM is an imaging biomarker for chronic glial activation in multiple sclerosis lesions
Gillen, K. M., Mubarak, M., Park, C., Ponath, G. D., Zhang, S., Dimov, A., Levine-Ritterman, M., Toro, S., Huang, W., Amici, S. A., et al. (2021) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51338 · Cited by 84
Calvi, A., Prados, F., Tur, C., Chard, D., Stutters, J., Angelis, F. D., John, N. A., Williams, T. E., Doshi, A., Samson, R. S., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000200144 · Cited by 80
Clinical applications at ultrahigh field (7 T). Where does it make the difference?
Trattnig, S., Bogner, W., Gruber, S., Szomolányi, P., Juráš, V., Robinson, S., Zbýň, Š., & Haneder, S. (2015) · NMR in Biomedicine · doi:10.1002/nbm.3272 · Cited by 79
In vivo imaging of chronic active lesions in multiple sclerosis
Calvi, A., Haider, L., Prados, F., Tur, C., Chard, D., & Barkhof, F. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458520958589 · Cited by 89
Kwong, K. C. N. K., Mollison, D., Meijboom, R., York, E. N., Kampaite, A., Thrippleton, M. J., Chandran, S., & Waldman, A. D. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256845 · Cited by 85
Common Peripheral Immunity Mechanisms in Multiple Sclerosis and Alzheimer's Disease
Rossi, B., Santos-Lima, B., Terrabuio, E., Zenaro, E., & Constantin, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.639369 · Cited by 84
Brain iron accumulation in Wilson disease: a post mortem 7 Tesla MRI – histopathological study
Dušek, P., Bahn, E., Litwin, T., Jabłonka-Salach, K., Łuciuk, A., Huelnhagen, T., Madai, V. I., Dieringer, M. A., Bulska, E., Knauth, M., et al. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12341 · Cited by 77
Dynamics of brain iron levels in multiple sclerosis
Khalil, M., Langkammer, C., Pichler, A., Pinter, D., Gattringer, T., Bachmaier, G., Ropele, S., Fuchs, S., Enzinger, C., & Fazekas, F. (2015) · Neurology · doi:10.1212/wnl.0000000000001679 · Cited by 76
Age‐related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis
Geraldes, R., Esiri, M. M., DeLuca, G. C., & Palace, J. A. (2016) · Brain Pathology · doi:10.1111/bpa.12460 · Cited by 77
7 Tesla Magnetic Resonance Imaging to Detect Cortical Pathology in Multiple Sclerosis
Yao, B., Hametner, S., van Gelderen, P., Merkle, H., Chen, C., Lassmann, H., Duyn, J., & Bagnato, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108863 · Cited by 78
Zhang, Y., Gauthier, S. A., Gupta, A. K., Chen, W., Comunale, J. P., Chiang, G. C.-Y., Zhou, D., Askin, G., Zhu, W., Pitt, D., et al. (2016) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4825 · Cited by 72
Longitudinal MR Imaging of Iron in Multiple Sclerosis: An Imaging Marker of Disease
Walsh, A. J. L., Blevins, G., Lebel, R. M., Seres, P., Emery, D. J., & Wilman, A. H. (2013) · Radiology · doi:10.1148/radiol.13130474 · Cited by 70
Kenkhuis, B., van Eekeren, M., Parfitt, D. A., Ariyürek, Y., Banerjee, P., Priller, J., van der Weerd, L., & van Roon‐Mom, W. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.04.006 · Cited by 71
Rudko, D. A., Solovey, I., Gati, J. S., Kremenchutzky, M., & Menon, R. S. (2014) · Radiology · doi:10.1148/radiol.14132475 · Cited by 68
Elliott, C., Rudko, D. A., Arnold, D. L., Fetco, D., Elkady, A. M., Araújo, D., Zhu, B. Y., Gafson, A., Tian, Z., Belachew, S. M., et al. (2023) · Multiple Sclerosis Journal · doi:10.1177/13524585231162262 · Cited by 68
Paramagnetic rim lesions in multiple sclerosis: Comparison of visualization at 1.5-T and 3-T MRI
Hemond, C. C., Reich, D. S., & Dundamadappa, S. K. (2022) · American Journal of Roentgenology · doi:10.2214/ajr.21.26777 · Cited by 66
Multiple sclerosis lesion geometry in quantitative susceptibility mapping (QSM) and phase imaging
Eskreis‐Winkler, S., Deh, K., Gupta, A. K., Liu, T., Wisnieff, C., Jin, M. M., Gauthier, S. A., Wang, Y., & Spincemaille, P. (2014) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24745 · Cited by 65
Potential role of iron in repair of inflammatory demyelinating lesions
Lee, N. J., Ha, S.-K., Sati, P., Absinta, M., Nair, G., Luciano, N. J., Leibovitch, E. C., Yen, C. C., Rouault, T. A., Silva, A. C., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126809 · Cited by 67
Amide proton transfer CEST of the cervical spinal cord in multiple sclerosis patients at 3T
By, S., Barry, R. L., Smith, A. K., Lyttle, B. D., Box, B. A., Bagnato, F. R., Pawate, S., & Smith, S. A. (2017) · Magnetic Resonance in Medicine · doi:10.1002/mrm.26736 · Cited by 64
Pallebage‐Gamarallage, M. M., Foxley, S., Menke, R., Huszár, I. N., Jenkinson, M., Tendler, B. C., Wang, C., Jbabdi, S., Turner, M. R., Miller, K. L., et al. (2018) · BMC Neuroscience · doi:10.1186/s12868-018-0416-1 · Cited by 64
Iron chelation and multiple sclerosis
Weigel, K. J., Lynch, S. G., & LeVine, S. M. (2014) · ASN NEURO · doi:10.1042/an20130037 · Cited by 63
Cortical and phase rim lesions on 7 T MRI as markers of multiple sclerosis disease progression
Treaba, C. A., Conti, A., Klawiter, E. C., Barletta, V. T., Herranz, E., Mehndiratta, A., Russo, A. W., Sloane, J. A., Kinkel, R. P., Toschi, N., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab134 · Cited by 62
Dušek, P., Dezortová, M., & Wuerfel, J. T. (2013) · International review of neurobiology · doi:10.1016/b978-0-12-410502-7.00010-7 · Cited by 60
Barquero, G., Rosa, F. L., Kebiri, H., Lu, P., Rahmanzadeh, R., Weigel, M., Fartaria, M. J., Kober, T., Théaudin, M., Pasquier, R. D., et al. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102412 · Cited by 60
Chronic active lesions in multiple sclerosis: classification, terminology, and clinical significance
Dal‐Bianco, A., Oh, J., Sati, P., & Absinta, M. (2024) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864241306684 · Cited by 61
Magnetic resonance frequency shifts during acute MS lesion formation
Wiggermann, V., Hernández‐Torres, E., Vavasour, I. M., Moore, G. R. W., Laule, C., MacKay, A. L., Li, D. K. B., Traboulsee, A. L., & Rauscher, A. (2013) · Neurology · doi:10.1212/wnl.0b013e31829bfd63 · Cited by 60
Untangling the R2* contrast in multiple sclerosis: A combined MRI-histology study at 7.0 Tesla
Bagnato, F. R., Hametner, S., Boyd, E. C., Endmayr, V., Shi, Y., Ikonomidou, V. N., Chen, G., Pawate, S., Lassmann, H., Smith, S. A., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193839 · Cited by 59
Metadata
- Authors
- Bagnato, F., Hametner, S., Yao, B., van Gelderen, P., Merkle, H., Cantor, F. K., Lassmann, H., & Duyn, J. H.
- Affiliations
- National Institutes of Health (US)
- Medical University of Vienna (AT)
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-12-01
- Volume
- 134
- Issue
- 12
- Pages
- 3602-3615
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC3235560
- OpenAlex
- W2154189431
- Cited by
- 351
- References
- 65
- Citations by year
- 2026: 14 · 2025: 19 · 2024: 29 · 2023: 33 · 2022: 32 · 2021: 25 · 2020: 22 · 2019: 18 · 2018: 18 · 2017: 22 · 2016: 35 · 2015: 24 · 2014: 28 · 2013: 19 · 2012: 13
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Brain (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- multiple sclerosis, iron accumulation, r2 relaxivity, gradient echo MRI, 7T MRI, white matter lesions, normal-appearing white matter, ferritin, oligodendrocytes, microglia, macrophages, microbleeds, myelin
- MeSH terms
- Brain, Humans, Image Processing, Computer-Assisted, Iron, Magnetic Resonance Imaging, Multiple Sclerosis, Myelin Sheath, Nerve Fibers, Myelinated
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
